{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:35:44Z","timestamp":1773300944650,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40249-018-0503-7","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T10:15:33Z","timestamp":1543313733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Parasite reduction ratio one day after initiation of artemisinin-based combination therapies and its relationship with parasite clearance time in acutely malarious children"],"prefix":"10.1186","volume":"7","author":[{"given":"Kazeem","family":"Akano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Godwin","family":"Ntadom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chimere","family":"Agomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian T.","family":"Happi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onikepe A.","family":"Folarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace O.","family":"Gbotosho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olugbenga","family":"Mokuolu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finomo","family":"Finomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy C.","family":"Ebenebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nma","family":"Jiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Ambe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robinson","family":"Wammanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Emechebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwabunmi K.","family":"Basorun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olubunmi A.","family":"Wewe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sikiru","family":"Amoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nnenna","family":"Ezeigwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Oguche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bayo","family":"Fatunmbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akintunde","family":"Sowunmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,7]]},"reference":[{"key":"503_CR1","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1128\/AAC.41.7.1413","volume":"41","author":"NJ White","year":"1997","unstructured":"White NJ. Assessment of the pharmacodynamics properties of antimalarial drugs in vivo. Antimicrob Agents Chemother. 1997;41:1413\u201322.","journal-title":"Antimicrob Agents Chemother"},{"key":"503_CR2","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1172\/JCI21682","volume":"113","author":"NJ White","year":"2004","unstructured":"White NJ. Antimalarial drug resistance. J Clin Invest. 2004;113:1084\u201392.","journal-title":"J Clin Invest"},{"key":"503_CR3","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1086\/650301","volume":"201","author":"K Stepniewska","year":"2010","unstructured":"Stepniewska K, Ashley E, Lee SJ, Anstey N, Barnes KI, Binh TQ, et al. In vivo parasitological measures of artemisinin susceptibility. J Infect Dis. 2010;201:570\u20136.","journal-title":"J Infect Dis"},{"key":"503_CR4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.parint.2016.09.002","volume":"65","author":"K Kobayashi","year":"2016","unstructured":"Kobayashi K, Kato K. Evaluating the use of heparin for synchronization of in vitro culture of Plasmodium falciparum. Parasitol Int. 2016;65:549\u201351.","journal-title":"Parasitol Int"},{"key":"503_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12936-017-1731-1","volume":"16","author":"NJ White","year":"2017","unstructured":"White NJ. Malaria parasite clearance. Malaria J. 2017;16:88.","journal-title":"Malaria J"},{"issue":"Suppl 1","key":"503_CR6","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/0035-9203(94)90460-X","volume":"88","author":"G Li","year":"1994","unstructured":"Li G, Guo X, Fu L, Jian H, Wang X. Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Trans R Soc Trop Med Hyg. 1994;88(Suppl 1):S5\u20136.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"503_CR7","unstructured":"World Health Organization. World malaria report. Geneva, Switzerland: World Health Organization. 2017. ISBN 978-92-4-156552-3. \n                    http:\/\/www.whi.int\/malaria\/publications\/world-malari-report-2017\/en\/\n                    \n                   Accessed on 13 Dec 2017."},{"key":"503_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.4269\/ajtmh.18-0115.","volume":"93","author":"JC Ebenebe","year":"2018","unstructured":"Ebenebe JC, Ntadom G, Ambe J, Wammanda R, Jiya N, Finomo F, et al. Efficacy of artemisinin-based combination treatments of uncomplicated falciparum malaria in under-five-year-old Nigerian children ten years after adoption as first-line antimalarials. Am J Trop Med Hyg. 2018;93:649\u201364. \n                    https:\/\/doi.org\/10.4269\/ajtmh.18-0115.","journal-title":"Am J Trop Med Hyg"},{"key":"503_CR9","doi-asserted-by":"crossref","unstructured":"World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000;94 Supp1:1\u201390.","DOI":"10.1016\/S0035-9203(00)90300-6"},{"issue":"Suppl 1","key":"503_CR10","first-page":"7","volume":"19","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Severe malaria. Tropical Med Int Health. 2014;19(Suppl 1):7\u2013131.","journal-title":"Tropical Med Int Health"},{"key":"503_CR11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12879-016-1565-4","volume":"16","author":"A Sowunmi","year":"2016","unstructured":"Sowunmi A, Akano K, Ayede AI, Ntadom G, Aderoyeje T, Adewoye EO, et al. Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria. BMC Inf Dis. 2016;16:240.","journal-title":"BMC Inf Dis"},{"key":"503_CR12","unstructured":"World Health Organization. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Geneva: World Health Organization. 2003. WHO\/HTM. RBM. 2003;50."},{"key":"503_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40249-016-0217-7","volume":"6","author":"A Sowunmi","year":"2017","unstructured":"Sowunmi A, Akano K, Ntadom G, Ayede AI, Ibironke FO, Aderoyeje T, et al. Therapeutic efficacy and effects of artemisinin-based combination treatments on uncomplicated Plasmodium falciparum malaria-associated anaemia in Nigerian children during seven years of adoption as first-line treatments. Infect Dis Poverty. 2017;6:36.","journal-title":"Infect Dis Poverty"},{"key":"503_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12879-016-2173-z","volume":"17","author":"A Sowunmi","year":"2017","unstructured":"Sowunmi A, Akano K, Ayede AI, Adewoye EO, Ntadom G, Fatunmbi B, et al. Early rising asexual parasitaemia in Nigerian children following a first dose of artemisinin-based combination treatments of falciparum malaria. BMC Inf Dis. 2017;17:110.","journal-title":"BMC Inf Dis."},{"key":"503_CR15","volume-title":"Epi Info Version 6. A Word Processing Data Base and Statistics Program for Public Health on IBM-compatible Microcomputers","author":"Anon","year":"1994","unstructured":"Anon. Epi Info Version 6. A Word Processing Data Base and Statistics Program for Public Health on IBM-compatible Microcomputers. Atlanta: Centers for Disease Control and Prevention; 1994."},{"key":"503_CR16","volume-title":"SPSS Inc.","author":"Anon. SPSS for Windows Release 20.0 (standard version)","year":"2011","unstructured":"Anon. SPSS for Windows Release 20.0 (standard version). SPSS Inc. USA: Chicago IL; 2011."},{"key":"503_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"I","author":"JM Bland","year":"1986","unstructured":"Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;I:307\u201310.","journal-title":"Lancet"},{"key":"503_CR18","volume-title":"National guidelines for diagnosis and treatment of malaria","author":"Federal Ministry of Health","year":"2015","unstructured":"Federal Ministry of Health. National guidelines for diagnosis and treatment of malaria. 3rd ed. Nigeria: Federal Ministry of Health; 2015. \n                    http:\/\/www.nmcp.gov.ng\n                    \n                   Accessed on 07 Feb 2016","edition":"3"},{"key":"503_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40249-016-0165-2","volume":"5","author":"A Sowunmi","year":"2016","unstructured":"Sowunmi A, Akano K, Ayede AI, Ntadom G, Adewoye EO, Fatunmbi B, et al. Therapeutic efficacy and effects of artesunate-amodiaquine and artemether-lumefantrine on malaria-associated anaemia in \u2264 2 years old Nigerian children with uncomplicated Plasmodium falciparum malaria during ten years of adoption as first-line treatments. Inf Dis Poverty. 2016;5:70.","journal-title":"Inf Dis Poverty"},{"key":"503_CR20","doi-asserted-by":"publisher","first-page":"235498","DOI":"10.4303\/mcce\/235498","volume":"1","author":"A Sowunmi","year":"2012","unstructured":"Sowunmi A, Okuboyejo TM, Gbotosho GO, Happi CT. Early changes in Plasmodium falciparum asexual and sexual populations in children with acute infections following treatment with artemisinin-based combination drugs. Mal Chemother Ctrl Elim. 2012;1:235498. \n                    https:\/\/doi.org\/10.4303\/mcce\/235498\n                    \n                  .","journal-title":"Mal Chemother Ctrl Elim"},{"key":"503_CR21","unstructured":"Global Malaria Programme WHO. Update on artemisinin resistance. April 2012. Available from: http\/\/www who.int\/malaria\/publications\/atoz\/updateartemisininresistanceapr2012\/en. Accessed 23 Oct 2013."},{"key":"503_CR22","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/S0140-6736(12)60484-X","volume":"379","author":"AP Phyo","year":"2012","unstructured":"Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379:1960\u20136.","journal-title":"Lancet"},{"key":"503_CR23","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/cid\/ciw388","volume":"63","author":"AP Phyo","year":"2016","unstructured":"Phyo AP, Ashley EA, Anderson TJC, Bozdech Z, Carrara VI, Sriprawat K, et al. Declining efficacy of artemisinin combination therapy against P. falciparum malaria on the Thai-Myanmar border (2003-2013): the role of parasite genetic factors. Clin Inf Dis. 2016;63:784\u201391.","journal-title":"Clin Inf Dis"},{"key":"503_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","volume":"17","author":"M Imwong","year":"2017","unstructured":"Imwong M, Suwannasin K, Kunasol C, Sutawong K, Mayxay M, Rekol H, et al. The spread of artemisinin-resistant plasmodium falciparum in the greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect Dis. 2017;17:491\u20137.","journal-title":"Lancet Infect Dis"},{"key":"503_CR25","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","volume":"373","author":"D M\u00e9nard","year":"2016","unstructured":"M\u00e9nard D, Khim N, Begham J, Adegnika AA, Shafiul-Alam M, Amodu O, et al. For the KARMA consortium: a worldwide map of Plasmodium falciparum K13-propeller polymorphism. New Engl J Med. 2016;373:2453\u201364.","journal-title":"New Engl J Med"},{"key":"503_CR26","doi-asserted-by":"publisher","first-page":"26005","DOI":"10.1371\/journal.pone.0026005","volume":"6","author":"S Borrmann","year":"2011","unstructured":"Borrmann S, Sasi P, Mwai L, Bashraheil M, Abdallah A, Muriithi S, et al. Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast. PLoS One. 2011;6:26005.","journal-title":"PLoS One"},{"key":"503_CR27","doi-asserted-by":"publisher","first-page":"936","DOI":"10.4269\/ajtmh.2011.10-0722","volume":"84","author":"GO Gbotosho","year":"2011","unstructured":"Gbotosho GO, Sowunmi A, Happi CT, Okuboyejo TM. Therapeutic efficacies of artemisinin-based combination therapies in Nigerian children with uncomplicated falciparum malaria during five years of adoption as first-line treatments. Am J Trop Med Hyg. 2011;84:936\u201343.","journal-title":"Am J Trop Med Hyg."}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-018-0503-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40249-018-0503-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-018-0503-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T19:10:44Z","timestamp":1575659444000},"score":1,"resource":{"primary":{"URL":"https:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-018-0503-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["503"],"URL":"https:\/\/doi.org\/10.1186\/s40249-018-0503-7","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"16 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the National Health Research Ethics Committee, Abuja, Nigeria [NHREC\/01\/01\/2007\u201328\/10\/2013 (29 October 2013), NHREC\/01\/01\/2007\u201322\/10\/2014 (30 October 2014)]. Written informed consents were obtained from the parents\/guardians of the participating children.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}